Anticoagulant therapy with rivaroxaban in a young patient  with paroxysmal nocturnal hemoglobinuria

Publisher: John Wiley & Sons Inc

E-ISSN: 2050-0904|3|10|790-792

ISSN: 2050-0904

Source: Clinical Case Reports, Vol.3, Iss.10, 2015-10, pp. : 790-792

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Key Clinical MessageThe new direct oral anticoagulants such us rivaroxaban, could play an important role in the anticoagulant treatment of patients with paroxysmal nocturnal hemoglobinuria where anticoagulant treatment is complex to run, since they have shown a reduction in serious bleeding complications compared to antithrombotic therapy with classical vitamin k antagonist.